Cargando…

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients

(1) Background: Fibroblast growth factor 23 (FGF23) is predominantly secreted from bone and plays an important role in mineral balance in chronic kidney disease. However, the relationship between FGF23 and bone mineral density (BMD) in chronic hemodialysis (CHD) patients remains unclear. (2) Methods...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wen-Teng, Fang, Yu-Wei, Chen, Mingchih, Liou, Hung-Hsiang, Lee, Chung-Jen, Tsai, Ming-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964480/ https://www.ncbi.nlm.nih.gov/pubmed/36836085 http://dx.doi.org/10.3390/jcm12041550

Ejemplares similares

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2023)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022)

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
por: Zheng, Shubei, et al.
Publicado: (2018)

Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients
por: Wu, Yin-Ting, et al.
Publicado: (2020)

Association of Serum Aluminum Levels with Mortality in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk, Malgorzata, et al.
Publicado: (2021)

Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients
por: Wang, Chih-Hsien, et al.
Publicado: (2020)

Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients
por: Bouksila, Mouna, et al.
Publicado: (2019)

Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2019)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4
por: Tsai, Ming-Hsien, et al.
Publicado: (2016)

A New Predictive Equation for Estimating Serum Ionized Calcium Levels in Patients on Chronic Hemodialysis
por: Hung, Wei-Li, et al.
Publicado: (2023)

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Correlation between serum leptin and bone mineral density in hemodialysis patients
por: Ghorban-Sabbagh, Mahin, et al.
Publicado: (2016)

Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients
por: Kuo, Chiu-Huang, et al.
Publicado: (2018)

Association between peripheral arterial occlusive disease and cardiothoracic ratio in patients on chronic hemodialysis
por: Liou, Kang-Yi, et al.
Publicado: (2016)

Serum calcification propensity and its association with biochemical parameters and bone mineral density in hemodialysis patients
por: Kim, Hyunsook, et al.
Publicado: (2023)

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
por: Egli-Spichtig, Daniela, et al.
Publicado: (2023)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Impact of Pre-Transplant Parathyroidectomy on Graft Survival: A Comparative Study of Renal Transplant Patients (2005–2015)
por: Tsai, Ming-Hsien, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease
por: Raji, Yemi R, et al.
Publicado: (2022)

Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients
por: Hori, Mayuko, et al.
Publicado: (2021)

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study
por: Kuo, Te-Hui, et al.
Publicado: (2019)

High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients
por: Kandarini, Yenny, et al.
Publicado: (2022)

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020)

Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa
por: Otani, Makoto, et al.
Publicado: (2008)

Intact fibroblast growth factor 23 and fragments in plasma from Gambian children
por: Braithwaite, V., et al.
Publicado: (2012)

Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2013)

Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
por: Hou, Jia-Sian, et al.
Publicado: (2020)

Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
por: El-Hodhod, Mostafa Abdel-Aziz, et al.
Publicado: (2012)

Association between Serum Fibroblast Growth Factor 21 Levels and Bone Mineral Density in Postmenopausal Women
por: Choi, Hoon Sung, et al.
Publicado: (2018)

Sites of Peripheral Artery Occlusive Disease as a Predictor for All-Cause and Cardiovascular Mortality in Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2015)

Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study
por: Ishigami, Junichi, et al.
Publicado: (2022)

Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients
por: Wang, Chih-Hsien, et al.
Publicado: (2016)

High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
por: Gravesen, Eva, et al.
Publicado: (2013)

Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients
por: Lin, Hsin-Hung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0e6uf7slqepvfu40roka0k1ut6